Ling T L, Combs D L
J Pharm Sci. 1987 Apr;76(4):289-94. doi: 10.1002/jps.2600760405.
The ocular bioavailability of 0.5% [14C]ketorolac tromethamine administered topically (50 microL) to the eye was determined. The ocular bioavailability of ketorolac was 4% in anesthetized rabbits and was determined by comparing drug concentrations in the aqueous humor after topical application with those obtained after intracameral injection of an equivalent dose of 0.25 mg of ketorolac tromethamine per eye. Although ketorolac administered to the eye was completely absorbed systemically, concentrations of ketorolac (AUC) were, on the average, 13 times higher in the aqueous humor than in plasma after topical administration. In a separate ocular distribution study, peak concentrations of radioactivity were achieved in the ocular tissues and in plasma within 1 h post instillation. Concentrations of total radioactivity were highest in the cornea and sclera and lowest in the lens.
测定了将0.5%[¹⁴C]酮咯酸氨丁三醇局部(50微升)滴入眼内后的眼部生物利用度。在麻醉兔中,酮咯酸的眼部生物利用度为4%,通过将局部应用后房水中的药物浓度与每只眼前房注射等效剂量0.25毫克酮咯酸氨丁三醇后获得的浓度进行比较来确定。尽管眼部给药的酮咯酸可被完全吸收进入全身循环,但局部给药后,房水中酮咯酸的浓度(AUC)平均比血浆中高13倍。在另一项眼部分布研究中,滴入后1小时内眼部组织和血浆中放射性达到峰值浓度。总放射性浓度在角膜和巩膜中最高,在晶状体中最低。